No Detail Found!

Clinical and Haematological Picture of Multi-transfused Thalassaemia Major Patients at a Center in Pakistan.

Author(s)
Suhaib Ahmed Department of Haematology, Islamic International Medical College, Riphah International University, Islamabad, Pakistan
Zohra Jabeen Wazir Thalassemia Treatment Center, Pak Thalassemia Welfare Society, Rawalpindi, Pakistan
Ishrat Abdul Qayyum Genetics Resource Center, Rawalpindi, Pakistan
Abstract
Objective: To describe the clinical and haematological picture of multiply transfused patients of thalassaemia major at a treatment center in Pakistan. Study Design: Descriptive cross-sectional. Place and Duration of Study: The study was conducted at Thalassaemia Treatment Centre Rawalpindi. The study was done between Jan 1994 and May 2017. Materials and Methods: A total of 383 patients of thalassaemia major (TM) on regular blood transfusions were examined for various clinical and haematological parameters. In addition case records of 101 patients of TM who died during treatment were also studied. Results: In the 383 patients on treatment 328 (86%) were born to consanguineous parents, 246 (64%) were from lower socio-economic group, 85 (22%) had one or more affected siblings, 145 (38%) had hepatomegaly, 191 (50%) had splenomegaly, 42 (11%) had undergone splenectomy and 187 (49%) had never received iron chelation therapy. Height and weight in the 383 patients on treatment showed marked stunting. Median age of the 383 patients on treatment was 104 months as compared to 119 months in the deceased group of patients (p=0.0263). Pre-transfusion Hb in the alive patients (7.1 g/dL) was higher than in the deceased patients (6.4 g/dL) (p=0.0142). Ferritin level in the patients on treatment (3698 µg/L) was lower than in the deceased patients (4616 µg/L) (p=0.0069). In the 383 patients on treatment 141 (36.8%) were HCV positive. Conclusion: Majority of the patients at a thalassaemia treatment center are chronically under-transfused and have moderate to severe growth retardation. They get inadequate iron chelation resulting in high mortality before tenth year of life.
Publication Details
Page(s) 52-56
DOI DOI not available
Published Journal: Journal of Islamic International Medical College, Volume: 13, Issue: 2, Year: 2018

Request the full text from PASTIC

References
ModellB,DarlisonM., 2008.Global epidemiology of haemoglobin disorders and derived service indicators,Bull World Health Organ 86 480 -7
AngastiniotisM,ModellB, 1998.Global epidemiology of hemoglobin disorders,Ann NY Acad Sci 850 251 -69
CaoA, 1987.Results of programmes for antenatal detection of thalassaemia in reducing the incidence of the disorder,Blood Rev 1 169 -76
Al-GazaliL,HamamyH,Al-Arrayad S, 2006.Genetic disorders in the Arab world,BMJ 333 831 -4
WeatherallDJ, 2011.The challenge of haemoglobinopathies in resource-poor countries,Br J Haematol 154 736 -44
AhmedS,SaleemM,ModellB,PetrouM., 2002.Screening extended families for genetic haemoglobin disorders in Pakistan,N Engl J Med 347 1162 -8
KhattakMF,SaleemM., 1992.Prevalence of heterozygous - thalassaemia in the Northern areas of Pakistan,J Pak Med Assoc 42 32 -4
AhmedS., .An approach for the prevention of thalassaemia in Pakistan,PhD Thesis -
AsifN,HassanK., 2016.Management of Thalassemia in Pakistan,JIMDC 5 152 -3
AzizS,Noor-,-AinW,MajeedR,KhanMA,QayumI,AhmedI, 2012.Growth centile charts (anthropometric measurement) of Pakistani pediatric population,J Pak Med Assoc 62 367 -77
NasirJA,ZaidiSAA, 2009.Modelling survival data of thalassaemia patients in Pakistan,J Ayub Med Coll Abbottabad 21 142 -5
Borgna-PignattiC,RigolottoS,De StefanoP,ZhaoH,CapelliniMD,Del VecchioG, 2004.Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine,Haematologica 89 1187 -93
CappelliniMD,CohenA,PorterJ,TaherA,ViprakasitV, 2013.Guidelines for the management of transfusion dependent thalassaemia (TDT),Nicosia: Thalassaemia International Federation TIF Publication No 20 -
HershkoC, 2010.Pathogenesis and management of iron toxicity in thalassemia,Ann NY Acad Sci 1202 1 -9
KhanD,CheemaAN,AnwarM,KhanFA, 2010., 4 580 -5
TienboonP,SanguansermsriT,FuchsGJ, 1996.Malnutrition and growth abnormalities in children with beta thalassemia major,Southeast Asian J Trop Med Public Health 27 356 -61
NazirS,FarazA,ShahzadN,AliN,KhanMA,IqbalM, 2014.Prevalence of HCV in β-thalassemia major patients visiting tertiary care hospitals in Lahore - Pakistan,Adv Life Sci 1 197 -01
DinG,MalikS,AliI,AhmedS,DastiJI, 2014.Prevalence of hepatitis C virus infection among thalassemia patients: a perspective from a multi-ethnic population of Pakistan,Asian Pac J Trop Med 7 127 -33
FisherDG,HessKL,ErlyanaE,ReynoldsGL,CumminsCA,AlonzoTA, 2015.Comparison of Rapid Point-of-Care Tests for Detection of Antibodies to Hepatitis C Virus,Open Forum Infect Dis 2 ofv101 -
HayderI,AhmedW,AlamSE, 2012.Comparison of Different ICT Kits for HBsAg and Anti HCV Using Gold Standard ELISA,Pak J Med Res 51 72 -5
AhmedS,SaleemM,PetrouM,SultanaN,RaashidY,WaqarA, 2000.Prenatal diagnosis of -thalassaemia in Pakistan: experience in a Muslim country,PrenatDiagn 20 378 -83
NaseemS,AhmedS, 2008.Impediments to prenatal diagnosis for beta thalassaemia: experiences from Pakistan,Prenat Diagn 28 1116 -8
BittlesAH,GrantJC,ShamiSA, 1993.An evaluation of consanguinity as a determinant of reproductive behaviour and mortality in Pakistan,Int J Epidemiol 22 463 -7
AnsariSH,ShamsiTS,AshrafM,PerveenK,FarzanaT,BorhanyM, 2011.Efficacy of Hydroxyurea in Providing Transfusion Independence in β-Thalassemia,J Pediatr Hematol Oncol 33 339 -43
ShamsiTS,HashmiK,AdilS,AhmadP,IrfanM,RazaS, 2008.The stem cell transplant program in Pakistan-the first decade,Bone Marrow Transplantation 42 114 -7
0

Citations

0

Downloads

76

Views